Drawing for BLUESIGHT INSIGHTS

USPTO serial 90458463

BLUESIGHT INSIGHTS

Reviewed by CopyMark Law Group

Reg. 6560599Status 700Renewal
Filing date
Status date
Registration date
Nov 16, 2021
Examiner
MULLEN, MARK
Law office
TMO LAW OFFICE 111

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BLUESIGHT INSIGHTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory B. Phillips

Gregory B. Phillips KNOBBE MARTENS OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Providing temporary use of non-downloadable computer software for supply chain management of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for use in supply chain management of pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information regarding cost-effective alternatives and products for pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternatives and products in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding cost-effective alternative suppliers in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Software as a service (SAAS) services featuring software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with purchase pricing, budgeting, discounts, and rebates; Software as a service (SAAS) services featuring software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Software as a service (SAAS) services featuring software for assessing, reviewing and reporting data trends found in prescription and medication records; Software as a service (SAAS) services featuring software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medicationsACTIVEDec 7, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 26, 2023ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 4, 2023NURCNOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED—
May 27, 2023COC.CORRECTION UNDER SECTION 7 - PROCESSED—
May 9, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 3, 2023ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 23, 2022ES7RTEAS SECTION 7 REQUEST RECEIVED—
Nov 16, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 31, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 31, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 11, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 23, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 20, 2021DOCKASSIGNED TO EXAMINER—
Apr 10, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 14, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance